Boyer, Patrice

Social phobia in general health care: an unrecognised undertreated disabling disorder

Weiller, E., Bisserbe, J. C., Boyer, P., Lepine, J. P., & Lecrubier, Y. (1996) · British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 219

Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison

Poirier, M.-F., & Boyer, P. (1999) · British Journal of Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 185

Novelty seekers and impulsive subjects are low in morningness

Caci, H., Robert, P., & Boyer, P. (2004) · European Psychiatry

Personality Traits and PsychologyCircadian rhythm and melatonin

Cited by 172

The Spielberger trait anxiety inventory measures more than anxiety

Caci, H., Baylé, F. J., Dossios, C., Robert, P., & Boyer, P. (2003) · European Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychometric Methodologies and Testing

Cited by 93

A Randomized, Placebo-Controlled Trial of Sertraline for Prophylactic Treatment of Highly Recurrent Major Depressive Disorder

Lépine, J.-P., Caillard, V., Bisserbe, J.-C., Troy, S., Hotton, J.-M., Boyer, P., & For the PREVERS Investigators (2004) · American Journal of Psychiatry

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 83

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial

Rosenthal, J. Z., Boyer, P., Vialet, C., Hwang, E., & Tourian, K. A. (2013) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 37

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

Goodwin, G. M., Boyer, P., Emsley, R., Rouillon, F., & de Bodinat, C. (2013) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 20

S.06.05 Relevance of neuroplasticity and cellularresilience in bipolar disorder and depression: Evidence from neuroimaging and cognitive studies

Fossati, P., & Boyer, P. (2004) · European Neuropsychopharmacology

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 1